Table of Contents Chapter 1 Overview of Blood Lancets 1.1 Definition of Blood Lancets in This Report 1.2 Commercial Types of Blood Lancets 1.2.1 Safety Lancets 1.2.2 Homecare Lancets 1.2.3 Other 1.3 Downstream Application of Blood Lancets 1.3.1 Cholesterol Tests 1.3.2 Glucose Tests 1.3.3 Others 1.4 Development History of Blood Lancets 1.5 Market Status and Trend of Blood Lancets 2013-2023 1.5.1 Global Blood Lancets Market Status and Trend 2013-2023 1.5.2 Regional Blood Lancets Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Blood Lancets 2013-2017 2.2 Sales Market of Blood Lancets by Regions 2.2.1 Sales Volume of Blood Lancets by Regions 2.2.2 Sales Value of Blood Lancets by Regions 2.3 Production Market of Blood Lancets by Regions 2.4 Global Market Forecast of Blood Lancets 2018-2023 2.4.1 Global Market Forecast of Blood Lancets 2018-2023 2.4.2 Market Forecast of Blood Lancets by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Blood Lancets by Types 3.2 Sales Value of Blood Lancets by Types 3.3 Market Forecast of Blood Lancets by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Blood Lancets by Downstream Industry 4.2 Global Market Forecast of Blood Lancets by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Blood Lancets Market Status by Countries 5.1.1 North America Blood Lancets Sales by Countries (2013-2017) 5.1.2 North America Blood Lancets Revenue by Countries (2013-2017) 5.1.3 United States Blood Lancets Market Status (2013-2017) 5.1.4 Canada Blood Lancets Market Status (2013-2017) 5.1.5 Mexico Blood Lancets Market Status (2013-2017) 5.2 North America Blood Lancets Market Status by Manufacturers 5.3 North America Blood Lancets Market Status by Type (2013-2017) 5.3.1 North America Blood Lancets Sales by Type (2013-2017) 5.3.2 North America Blood Lancets Revenue by Type (2013-2017) 5.4 North America Blood Lancets Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Blood Lancets Market Status by Countries 6.1.1 Europe Blood Lancets Sales by Countries (2013-2017) 6.1.2 Europe Blood Lancets Revenue by Countries (2013-2017) 6.1.3 Germany Blood Lancets Market Status (2013-2017) 6.1.4 UK Blood Lancets Market Status (2013-2017) 6.1.5 France Blood Lancets Market Status (2013-2017) 6.1.6 Italy Blood Lancets Market Status (2013-2017) 6.1.7 Russia Blood Lancets Market Status (2013-2017) 6.1.8 Spain Blood Lancets Market Status (2013-2017) 6.1.9 Benelux Blood Lancets Market Status (2013-2017) 6.2 Europe Blood Lancets Market Status by Manufacturers 6.3 Europe Blood Lancets Market Status by Type (2013-2017) 6.3.1 Europe Blood Lancets Sales by Type (2013-2017) 6.3.2 Europe Blood Lancets Revenue by Type (2013-2017) 6.4 Europe Blood Lancets Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Blood Lancets Market Status by Countries 7.1.1 Asia Pacific Blood Lancets Sales by Countries (2013-2017) 7.1.2 Asia Pacific Blood Lancets Revenue by Countries (2013-2017) 7.1.3 China Blood Lancets Market Status (2013-2017) 7.1.4 Japan Blood Lancets Market Status (2013-2017) 7.1.5 India Blood Lancets Market Status (2013-2017) 7.1.6 Southeast Asia Blood Lancets Market Status (2013-2017) 7.1.7 Australia Blood Lancets Market Status (2013-2017) 7.2 Asia Pacific Blood Lancets Market Status by Manufacturers 7.3 Asia Pacific Blood Lancets Market Status by Type (2013-2017) 7.3.1 Asia Pacific Blood Lancets Sales by Type (2013-2017) 7.3.2 Asia Pacific Blood Lancets Revenue by Type (2013-2017) 7.4 Asia Pacific Blood Lancets Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Blood Lancets Market Status by Countries 8.1.1 Latin America Blood Lancets Sales by Countries (2013-2017) 8.1.2 Latin America Blood Lancets Revenue by Countries (2013-2017) 8.1.3 Brazil Blood Lancets Market Status (2013-2017) 8.1.4 Argentina Blood Lancets Market Status (2013-2017) 8.1.5 Colombia Blood Lancets Market Status (2013-2017) 8.2 Latin America Blood Lancets Market Status by Manufacturers 8.3 Latin America Blood Lancets Market Status by Type (2013-2017) 8.3.1 Latin America Blood Lancets Sales by Type (2013-2017) 8.3.2 Latin America Blood Lancets Revenue by Type (2013-2017) 8.4 Latin America Blood Lancets Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Blood Lancets Market Status by Countries 9.1.1 Middle East and Africa Blood Lancets Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Blood Lancets Revenue by Countries (2013-2017) 9.1.3 Middle East Blood Lancets Market Status (2013-2017) 9.1.4 Africa Blood Lancets Market Status (2013-2017) 9.2 Middle East and Africa Blood Lancets Market Status by Manufacturers 9.3 Middle East and Africa Blood Lancets Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Blood Lancets Sales by Type (2013-2017) 9.3.2 Middle East and Africa Blood Lancets Revenue by Type (2013-2017) 9.4 Middle East and Africa Blood Lancets Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Blood Lancets 10.1 Global Economy Situation and Trend Overview 10.2 Blood Lancets Downstream Industry Situation and Trend Overview Chapter 11 Blood Lancets Market Competition Status by Major Manufacturers 11.1 Production Volume of Blood Lancets by Major Manufacturers 11.2 Production Value of Blood Lancets by Major Manufacturers 11.3 Basic Information of Blood Lancets by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Blood Lancets Major Manufacturer 11.3.2 Employees and Revenue Level of Blood Lancets Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Blood Lancets Major Manufacturers Introduction and Market Data 12.1 Improve Medical 12.1.1 Company profile 12.1.2 Representative Blood Lancets Product 12.1.3 Blood Lancets Sales, Revenue, Price and Gross Margin of Improve Medical 12.2 BD 12.2.1 Company profile 12.2.2 Representative Blood Lancets Product 12.2.3 Blood Lancets Sales, Revenue, Price and Gross Margin of BD 12.3 VWR 12.3.1 Company profile 12.3.2 Representative Blood Lancets Product 12.3.3 Blood Lancets Sales, Revenue, Price and Gross Margin of VWR 12.4 Sarstedt 12.4.1 Company profile 12.4.2 Representative Blood Lancets Product 12.4.3 Blood Lancets Sales, Revenue, Price and Gross Margin of Sarstedt 12.5 FDA 12.5.1 Company profile 12.5.2 Representative Blood Lancets Product 12.5.3 Blood Lancets Sales, Revenue, Price and Gross Margin of FDA 12.6 Wanjia 12.6.1 Company profile 12.6.2 Representative Blood Lancets Product 12.6.3 Blood Lancets Sales, Revenue, Price and Gross Margin of Wanjia 12.7 Huaian Meiyi 12.7.1 Company profile 12.7.2 Representative Blood Lancets Product 12.7.3 Blood Lancets Sales, Revenue, Price and Gross Margin of Huaian Meiyi 12.8 Shangdong Lianfa Medical 12.8.1 Company profile 12.8.2 Representative Blood Lancets Product 12.8.3 Blood Lancets Sales, Revenue, Price and Gross Margin of Shangdong Lianfa Medical Chapter 13 Upstream and Downstream Market Analysis of Blood Lancets 13.1 Industry Chain of Blood Lancets 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Blood Lancets 14.1 Cost Structure Analysis of Blood Lancets 14.2 Raw Materials Cost Analysis of Blood Lancets 14.3 Labor Cost Analysis of Blood Lancets 14.4 Manufacturing Expenses Analysis of Blood Lancets Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Safety Lancets Table Advantage and Disadvantage of Homecare Lancets Table Advantage and Disadvantage of Other Table Sales Volume of Blood Lancets by Regions 2013-2017 Table Sales Value of Blood Lancets by Regions 2013-2017 Table Production Volume of Blood Lancets by Regions 2013-2017 Table Global Sales Volume of Blood Lancets by Regions 2018-2023 Table Global Sales Value of Blood Lancets by Regions 2018-2023 Table Global Production Volume of Blood Lancets by Regions 2018-2023 Table Sales Volume of Blood Lancets by Types 2013-2017 Table Sales Value of Blood Lancets by Types 2013-2017 Table Sales Volume Forecast of Blood Lancets by Types 2018-2023 Table Sales Value Forecast of Blood Lancets by Types 2018-2023 Table Sales Volume of Blood Lancets by Downstream Industry 2013-2017 Table Sales Volume Forecast of Blood Lancets by Downstream Industry 2018-2023 Table North America Blood Lancets Sales by Countries (2013-2017) Table North America Blood Lancets Sales Share by Countries (2013-2017) Table North America Blood Lancets Revenue by Countries (2013-2017) Table North America Blood Lancets Revenue Market Share by Countries (2013-2017) Table North America Blood Lancets Sales by Type (2013-2017) Table North America Blood Lancets Sales Share by Type (2013-2017) Table North America Blood Lancets Revenue by Type (2013-2017) Table North America Blood Lancets Revenue Share by Type (2013-2017) Table North America Blood Lancets Sales by Downstream Industry (2013-2017) Table North America Blood Lancets Sales Share by Downstream Industry (2013-2017) Table Europe Blood Lancets Sales by Countries (2013-2017) Table Europe Blood Lancets Sales Share by Countries (2013-2017) Table Europe Blood Lancets Revenue by Countries (2013-2017) Table Europe Blood Lancets Revenue Market Share by Countries (2013-2017) Table Europe Blood Lancets Sales by Type (2013-2017) Table Europe Blood Lancets Sales Share by Type (2013-2017) Table Europe Blood Lancets Revenue by Type (2013-2017) Table Europe Blood Lancets Revenue Share by Type (2013-2017) Table Europe Blood Lancets Sales by Downstream Industry (2013-2017) Table Europe Blood Lancets Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Blood Lancets Sales by Countries (2013-2017) Table Asia Pacific Blood Lancets Sales Share by Countries (2013-2017) Table Asia Pacific Blood Lancets Revenue by Countries (2013-2017) Table Asia Pacific Blood Lancets Revenue Market Share by Countries (2013-2017) Table Asia Pacific Blood Lancets Sales by Type (2013-2017) Table Asia Pacific Blood Lancets Sales Share by Type (2013-2017) Table Asia Pacific Blood Lancets Revenue by Type (2013-2017) Table Asia Pacific Blood Lancets Revenue Share by Type (2013-2017) Table Asia Pacific Blood Lancets Sales by Downstream Industry (2013-2017) Table Asia Pacific Blood Lancets Sales Share by Downstream Industry (2013-2017) Table Latin America Blood Lancets Sales by Countries (2013-2017) Table Latin America Blood Lancets Sales Share by Countries (2013-2017) Table Latin America Blood Lancets Revenue by Countries (2013-2017) Table Latin America Blood Lancets Revenue Market Share by Countries (2013-2017) Table Latin America Blood Lancets Sales by Type (2013-2017) Table Latin America Blood Lancets Sales Share by Type (2013-2017) Table Latin America Blood Lancets Revenue by Type (2013-2017) Table Latin America Blood Lancets Revenue Share by Type (2013-2017) Table Latin America Blood Lancets Sales by Downstream Industry (2013-2017) Table Latin America Blood Lancets Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Blood Lancets Sales by Regions (2013-2017) Table Middle East and Africa Blood Lancets Sales Share by Regions (2013-2017) Table Middle East and Africa Blood Lancets Revenue by Regions (2013-2017) Table Middle East and Africa Blood Lancets Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Blood Lancets Sales by Type (2013-2017) Table Middle East and Africa Blood Lancets Sales Share by Type (2013-2017) Table Middle East and Africa Blood Lancets Revenue by Type (2013-2017) Table Middle East and Africa Blood Lancets Revenue Share by Type (2013-2017) Table Middle East and Africa Blood Lancets Sales by Downstream Industry (2013-2017) Table Middle East and Africa Blood Lancets Sales Share by Downstream Industry (2013-2017) Table Production Volume of Blood Lancets by Major Manufacturers 2013-2017 Table Production Value of Blood Lancets by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Blood Lancets Major Manufacturer Table Employees and Revenue Level of Blood Lancets Major Manufacturer Table Representative Blood Lancets Product One of Improve Medical Table Representative Blood Lancets Product Two of Improve Medical Table Blood Lancets Sales, Revenue, Price and Gross Margin of Improve Medical 2013-2017 Table Representative Blood Lancets Product One of BD Table Representative Blood Lancets Product Two of BD Table Blood Lancets Sales, Revenue, Price and Gross Margin of BD 2013-2017 Table Representative Blood Lancets Product One of VWR Table Representative Blood Lancets Product Two of VWR Table Blood Lancets Sales, Revenue, Price and Gross Margin of VWR 2013-2017 Table Representative Blood Lancets Product One of Sarstedt Table Representative Blood Lancets Product Two of Sarstedt Table Blood Lancets Sales, Revenue, Price and Gross Margin of Sarstedt 2013-2017 Table Representative Blood Lancets Product One of FDA Table Representative Blood Lancets Product Two of FDA Table Blood Lancets Sales, Revenue, Price and Gross Margin of FDA 2013-2017 Table Representative Blood Lancets Product One of Wanjia Table Representative Blood Lancets Product Two of Wanjia Table Blood Lancets Sales, Revenue, Price and Gross Margin of Wanjia 2013-2017 Table Representative Blood Lancets Product One of Huaian Meiyi Table Representative Blood Lancets Product Two of Huaian Meiyi Table Blood Lancets Sales, Revenue, Price and Gross Margin of Huaian Meiyi 2013-2017 Table Representative Blood Lancets Product One of Shangdong Lianfa Medical Table Representative Blood Lancets Product Two of Shangdong Lianfa Medical Table Blood Lancets Sales, Revenue, Price and Gross Margin of Shangdong Lianfa Medical 2013-2017